Feed ILMN
IL
Illumina
ILMN · NASDAQ
$188.29 -2.11% (-$4.06)
1M +1.95%
Market Cap $29.2B
P/E Ratio 34.38x
Div. Yield -
ROE 32.56%
Bulios Fair Price
$120.61
35.9% downside
Aktuální cena
$188.29
Podhodnoceno Férová hodnota Nadhodnoceno
Podle Bulios Fair Price je akcie ILMN aktuálně nadhodnocená vůči své tržní ceně. Jak to funguje?
Piotroski F-Score Moderate
6/9Valuation
17 /100
Expensive P/E 34.38x
EV/EBITDA 26.77x
P/FCF 31.39x
Growth
41 /100
Stable Rev. growth 1.82%
FCF growth 106.32%
Book val. growth 25.55%
Profitability
95 /100
Strong Gross margin 66.69%
Net margin 19.59%
FCF margin 21.46%
Quality
79 /100
Excellent ROIC 12.00%
ROE 32.56%
Asset turnover 0.65x
Debt
77 /100
Low Debt/Equity 0.94x
Current ratio 2.08x
Net debt/EBITDA 1.00x
Stability
42 /100
Moderate Beta 1.46x
Rev. volatility 1.08%
Profitable years 1
Zeptejte se StockBota na ILMN
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jacob Thaysen
Employees
8,600
Headquarters
San Diego
Nadcházející události
29 ŘÍJ
Earnings
Upcoming earnings report